A PHASE II STUDY OF PREOPERATIVE CAPECITABINE AND RADIATION THERAPY IN PATIENTS WITH RECTAL CANCER

被引：0
|
作者：
Cerezo, L. [1 ]
Martin Martin, M. [1 ]
Counago, F. [1 ]
Martin Angulo, M. [2 ]
Lopez, M. [1 ]
Marin, A. [1 ]
Cruz, A. [1 ]
Rios, P. [1 ]
机构：
[1] Hosp Univ Princesa, Radiat Oncol, Madrid, Spain
[2] Hosp Univ Principe Asturias, Med Oncol, Alcala De Henares, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
676
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [31] RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
    Wong, Stuart J.
    Winter, Kathryn
    Meropol, Neal J.
    Anne, Pramila Rani
    Kachnic, Lisa
    Rashid, Asif
    Watson, James C.
    Mitchell, Edith
    Pollock, Jondavid
    Lee, Robert Jeffrey
    Haddock, Michael
    Erickson, Beth A.
    Willett, Christopher G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1367 - 1375
  • [32] Phase I study of preoperative chemoradiation with temozolomide and capecitabine in patients with locally advanced rectal cancer
    Hong, Yong Sang
    Park, Seong Joon
    Kim, Jeong Eun
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Park, Jin-hong
    Kim, Jong Hoon
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
    Margarita García
    Mercedes Martinez-Villacampa
    Cristina Santos
    Valentin Navarro
    Alex Teule
    Ferran Losa
    Aleydis Pisa
    Maria Cambray
    Gemma Soler
    Laura Lema
    Esther Kreisler
    Agnes Figueras
    Xavier San Juan
    Francesc Viñals
    Sebastiano Biondo
    Ramon Salazar
    BMC Cancer, 15
  • [34] BEVACIZUMAB, CAPECITABINE, AMIFOSTINE, AND PREOPERATIVE HYPOFRACTIONATED ACCELERATED RADIOTHERAPY (HYPOARC) FOR RECTAL CANCER: A PHASE II STUDY
    Koukourakis, Michael I.
    Giatromanolaki, Alexandra
    Tsoutsou, Pelagia
    Lyratzopoulos, Nikolaos
    Pitiakoudis, Michael
    Kouklakis, George
    Chloropoulou, Pelagia A.
    Manolas, Kostantinos
    Sivridis, Efthimios
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 492 - 498
  • [35] Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
    Garcia, Margarita
    Martinez-Villacampa, Mercedes
    Santos, Cristina
    Navarro, Valentin
    Teule, Alex
    Losa, Ferran
    Pisa, Aleydis
    Cambray, Maria
    Soler, Gemma
    Lema, Laura
    Kreisler, Esther
    Figueras, Agnes
    Juan, Xavier San
    Vinals, Francesc
    Biondo, Sebastiano
    Salazar, Ramon
    BMC CANCER, 2015, 15
  • [36] Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
    Frakes, Jessica
    Mehta, Rutika
    Hoffe, Sarah E.
    Imanirad, Iman
    Jimenez, Maria E. Martinez
    Sanchez, Julian
    Malafa, Mokenge Peter
    Felder, Seth
    Dessureault, Sophie
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with locally advanced rectal cancer (LARC)
    Machiels, J.
    Coche, J.
    Scalliet, P.
    Van Cutsem, E.
    Roels, S.
    Canon, J.
    Coster, B.
    Kerger, J.
    Remouchamps, V.
    Haustermans, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [38] Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
    D Koeberle
    R Burkhard
    R von Moos
    R Winterhalder
    V Hess
    F Heitzmann
    T Ruhstaller
    L Terraciano
    J Neuweiler
    G Bieri
    C Rust
    M Toepfer
    British Journal of Cancer, 2008, 98 : 1204 - 1209
  • [39] Preoperative chemoradiation with capecitabine for rectal cancer in elderly patients: A phase I trial
    Liu, W.
    Tang, Y.
    Jin, J.
    Zhang, H.
    Yang, L.
    Ren, H.
    Fang, H.
    Wang, W.
    Song, Y.
    Liu, Y.
    Wang, S.
    Li, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S188 - S189
  • [40] A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.
    Tamberi, Stefano
    Grassi, Elisa
    Zingaretti, Chiara
    Papiani, Giorgio
    Pini, Sara
    Corbelli, Jody
    Di Bartolomeo, Maria
    Pietrantonio, Filippo
    Frassineti, Giovanni Luca
    Passardi, Alessandro
    Gelsomino, Fabio
    Marzola, Marina
    Banzi, Maria
    Bonetti, Andrea Vincent
    Petracci, Elisabetta
    Moretti, Chiara Carli
    Banchelli, Isabella
    Tassinari, Davide
    Ugolini, Giampaolo
    Nanni, Oriana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)
12345